Emvita 11 (RUBIMED AG)


Welcome to the PulseAid listing for the Emvita 11 drug offered from RUBIMED AG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: RUBIMED AG
NON-PROPRIETARY NAME: IRON, STRYCHNOS IGNATII SEED, CLAVICEPS PURPUREA SCLEROTIUM, COPPER, and SUS SCROFA PANCREAS
SUBSTANCE NAME: IRON; STRYCHNOS IGNATII SEED; CLAVICEPS PURPUREA SCLEROTIUM; COPPER; SUS SCROFA PANCREAS
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00


Emvita 11 HUMAN OTC DRUG Details:

Item DescriptionEmvita 11 from RUBIMED AG
LABELER NAME: RUBIMED AG
DEA SCHEDULE:
ACTIVE STRENGTH: 800; 18; 21; 21; 21([hp_C]/mL; [hp_M]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66343-023_406b8efc-3b8e-4661-9b60-81a75fc03a27
PRODUCT NDC: 66343-023
APPLICATION NUMBER:

Other IRON; STRYCHNOS IGNATII SEED; CLAVICEPS PURPUREA SCLEROTIUM; COPPER; SUS SCROFA PANCREAS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
RUBIMED AGEmvita 11